Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2006
11/15/2006EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006EP1363648B1 Agastache rugosa extract having anti-inflammatory activity and anti-atherogenic activity
11/15/2006EP1335919B1 Triazolo[4,5-d]pyrimidine derivatives as anti-thrombotic agents
11/15/2006EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006EP1323711B1 Novel phenylalanine derivatives
11/15/2006EP1309557B9 Amlodipine hemimaleate
11/15/2006EP1309323B1 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives
11/15/2006EP1254659B1 Stable emulsion compositions
11/15/2006EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006CN1863773A 四氢吡啶衍生物 Tetrahydropyridine derivatives
11/15/2006CN1863548A Methods and compositions for treating disorders of the extracellular matrix
11/15/2006CN1863542A Plant seed extract composition and process for producing the same
11/15/2006CN1863534A Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases
11/15/2006CN1863523A Application of L-NBP in preparation of medicine for preventing and curing celebralin farction
11/15/2006CN1861621A Process of preparing burdock glucoside and glucosidgen thereof
11/15/2006CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006CN1861178A Medicinal composition for treating primary hypertension and preparing method of tea agent thereof
11/15/2006CN1861171A Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine
11/15/2006CN1861146A Compound soft capsule 'Xueshuantong' for treating thrombus disease and its prepn. method
11/15/2006CN1861142A Medicine composition for treating coronary heart disease and its prepn. method
11/15/2006CN1861132A Medicine for treating ischemic cexebral apoplexia and its prepn. method
11/15/2006CN1861122A Traditional Chinese medicine prepn. used for treating apoplexia and obstruction of qi in the chest, and its prepn. method
11/15/2006CN1861112A Application of Qishen Yiqi dripping pills for preparing medicine to inhibit leakage of albumin
11/15/2006CN1861099A 蛇油软胶囊 Snake Oil Soft Capsule
11/15/2006CN1861088A Nasal drip liquor for treating rhinitis and nasosinusitis
11/15/2006CN1861087A High purity wild Radix scutellariae glucoside medicine composition, and application of making medicine to treat diseases of cardiovascular and cerebrovascular
11/15/2006CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006CN1861070A Use of tanshinone type compounds for preparing medicines to treat angiitis
11/15/2006CN1860898A Fat-control tea
11/15/2006CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006CN1284793C C-aryl glucoside sglt2 inhibitors
11/15/2006CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006CN1284589C Medicine for treating acute brain blood vessel disease and its preparation method
11/15/2006CN1284568C Chinese medicine preparation for treating coronary heart disease and rheumatic heart disease
11/15/2006CN1284560C Multifunctional external-applied ointment and production thereof
11/15/2006CN1284551C Chinese medicinal preparation and preparing method for acute cerebral infarction
11/15/2006CN1284544C Application of Hibiscus sabdariffa Linn extractive in preparing medicine for inhibiting cardiac and cerebral vascular diseases
11/15/2006CN1284541C Magnesium, potassium and calcium mixture and its usage
11/15/2006CN1284534C Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same
11/15/2006CN1284525C Production method of disodium adenosine triphosphate magnesium chloride injection
11/15/2006CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006US7135502 Colchinol derivatives as vascular damaging agents
11/14/2006US7135497 Spinal administration of at least one beta 2 adrenergic agonist such as clenbuterol and salbutamol; neurodegenerative diseases; improved locomotor function and neuromuscular strength
11/14/2006US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006US7135474 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
11/14/2006US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006US7135471 Aryl oximes
11/14/2006US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006US7135464 Method of administering decitabine
11/14/2006US7135453 Reagents and methods for smooth muscle therapies
11/14/2006US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006US7135189 Compositions and techniques for localized therapy
11/14/2006CA2379572C Polymorphic salt
11/14/2006CA2342271C Gem substituted hydroxamic acids
11/14/2006CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006CA2263846C Novel pyranoside derivatives
11/14/2006CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006WO2006118341A1 Novel lactam compound
11/09/2006WO2006118328A1 Degranulation inhibitor
11/09/2006WO2006118320A1 Thienopyrimidone compound
11/09/2006WO2006118316A1 Inhibitor for lipid accumulation in liver
11/09/2006WO2006118313A1 Novel polypeptide and use thereof
11/09/2006WO2006118299A1 Gpcr inhibitor
11/09/2006WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006WO2006118210A1 Method of preventing dihydropyridine compound from degradation
11/09/2006WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006WO2006117668A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament
11/09/2006WO2006117664A1 New dha derivatives and their use as medicaments
11/09/2006WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006WO2006117170A1 Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons
11/09/2006WO2006117165A2 Means and methods for the treatment of head injuries and stroke
11/09/2006WO2006117076A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006WO2006117075A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006WO2006116949A1 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis
11/09/2006WO2006116815A1 Composition for the control of cholesterol levels
11/09/2006WO2006116814A1 Composition and uses thereof
11/09/2006WO2006100021A8 Use of the mst protein for the treatment of a thromboembolic disorder
11/09/2006WO2006099940A8 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments
11/09/2006WO2005097087A3 Merged ion channel modulating compounds and uses thereof
11/09/2006US20060252943 Chemical process
11/09/2006US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006US20060252833 Improve efficiency when administered with conventional drugs; side effect reduction; Parkinson's disease therapy; administering a fatty acid
11/09/2006US20060252827 Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof
11/09/2006US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006US20060252806 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006US20060252805 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006US20060252797 Receptor regulator